Journal article icon

Journal article

How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?

Abstract:

Given that cardiovascular safety liabilities remain a major cause of drug attrition during preclinical and clinical development, adverse drug reactions, and post-approval withdrawal of medicines, the Medical Research Council Centre for Drug Safety Science hosted a workshop to discuss current challenges in determining, understanding and addressing 'Cardiovascular Toxicity of Medicines'. This article summarizes the key discussions from the workshop that aimed to address three major questions: (...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Expand authors...
Journal:
British journal of pharmacology
Volume:
163
Issue:
4
Pages:
675-693
Publication date:
2011-06-01
DOI:
EISSN:
1476-5381
ISSN:
0007-1188
Source identifiers:
118048
Language:
English
Keywords:
Pubs id:
pubs:118048
UUID:
uuid:4ff9f411-50fc-4741-af27-1a9a886dff83
Local pid:
pubs:118048
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP